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The discovery of Sestrins as p53 targets [1,2] suggested 
that these proteins are stress-inducible because they 
protect cells against various insults [2]. Sestrins have 
dual biochemical functions, as antioxidants that control 
the activity of peroxiredoxins which scavenge reactive 
oxygen species (ROS) [3] and as inhibitors of target of 
rapamycin complex 1 (TORC1) signaling [4,5]. Both 
ROS accumulation [6] and TORC1 activation [7,8] are 
associated with accelerated aging and development of 
age-associated pathologies in diverse organs and 
organisms, implicating Sestrins as anti-aging agents. 
Conversely, reduction of ROS accumulation with 
antioxidants or as a result of TORC1 inhibition [7-12] 
causes an extension of life span as well as health span. 
Indeed, we recently confirmed Drosophila Sestrin 
(dSesn) prevents age-associated pathologies including 
fat accumulation and cardiac and skeletal muscle 
degeneration by providing a feedback loop that prevents 
excessive TORC1 activation and ROS accumulation 
[4]. In this research perspective, we discuss the possible 
roles of Sestrins in diverse stress-induced patho-
physiological contexts that can result in premature 
aging and age-related diseases. We suggest that Sestrins 
provide critical  feedback regulation that adjust  metabo- 
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lic and stress responses to different environmental cues 
and evolutionary constraints. 
 
DNA damage 
 
Chronic exposure to genotoxic stress is known to 
accelerate aging, and mutations that disrupt proper 
DNA damage responses and interfere with DNA 
damage repair are associated with premature aging in 
humans [13]. Many studies have established that 
genotoxic stresses can inhibit protein and lipid 
synthesis, and that these coordinated responses may be 
essential for survival because reducing energy 
expenditure on macromolecule biosynthesis can divert 
scarce resources to the repair of damaged DNA [14]. 
Sestrins, as DNA damage-inducible proteins, may play 
a critical role in this process [15]. Both mammalian 
Sesn1 and Sesn2 are induced upon DNA damage in 
response to activation of p53 [1,2], and dSesn is also 
induced upon radiation-induced DNA damage (Figure 
1). Increased Sestrin abundance potentiates the activity 
of AMP-activated protein kinase (AMPK), thereby 
diminishing TORC1 activity [5]. Reduced TORC1 
activity inhibits anabolic pathway including protein and  
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anabolism upon genotoxic stress is likely to be 
important for minimizing new protein and membrane 
synthesis and use the energy that was thus saved to 
promote DNA repair. Therefore, DNA damage-
dependent induction of Sestrins may minimize the 
detrimental effects of DNA damage that contribute to 
accelerated aging and various pathologies that are 
associated with premature aging. 
 
Age-dependent accumulation of DNA damage can lead 
to cancer [13], one of the leading causes of mortality 
worldwide [18]. Therefore, Sestrin induction in 
response to DNA damage [1,2] may contribute to the 
many tumor suppressor functions carried out by p53 
[19]. In addition to inhibiting cell proliferation and 
promoting the death of cells with excessive DNA 
damage, p53 was recently found to inhibit TORC1 [14] 
and to suppress cell growth as well as cellular and 
organismal senescence [19-21]. We found that Sesn1 
and/or Sesn2 are critical mediators of p53-induced 
TORC1 inhibition in cultured cells and in mouse liver 
[5]. In addition, Sestrins can suppress the growth of 
some cancer cell lines [2] and loss of Sesn2 makes 
immortalized cells more susceptible to oncogenic 
transformation [5]. The SESN1 (6q21) and SESN2 
(1p35) loci are frequently deleted in a variety of human 
cancers [1,22,23], implicating loss of Sestrins in tumor 
progression and suggesting that Sestrin-dependent 
inhibition of TORC1 is critical for suppressing 
tumorigenesis spurred by age-dependent accumulation 
of damaged DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oxidative stress 
 
Oxidative stress not only can interfere with the proper 
flow of genomic information by oxidizing DNA and 
RNA, but also can damage other macromolecules such 
as proteins and lipids [6]. Accumulation of oxidative 
macromolecular damage causes cellular senescence, 
tissue aging and reduced life span [6], as well as 
neurodegeneration [24] and metabolic disorders [25], 
which are diseases associated with aging. Amongst the 
organelles that are affected by oxidative stress, 
mitochondria appear to be the most sensitive [6,26]. 
Moreover, damaged mitochondria are a major source of 
ROS [6], which escalates oxidative damage in stressed 
cells. Extensive mitochondrial dysfunction causes cell 
death, and in some cases can lead to neuronal or 
muscular degeneration [6,24,27]. To prevent the 
detrimental consequences of mitochondrial dysfunction, 
cells eliminate damaged mitochondria through an 
autophagic process, called mitophagy [28,29]. 
 
Sestrins are transcriptionally induced upon oxidative 
stress [2], and are important for cell survival under 
oxidative stress [2,3,30,31]. Sestrins can function as 
oxidoreductases in vitro and in vivo that lead to the 
reactivation of peroxiredoxin [3], and may be involved 
in reducing oxidative stress [30-32] by scavenging ROS 
and/or regenerating reduced peroxiredoxin [3]. 
Independent of their oxidoreductase activity, Sestrins 
induce autophagy by inhibition of TORC1 [5,33,34]. 
Enhanced autophagy results in more efficient 
elimination of ROS-producing damaged mitochondria 
in stressed cells [28,29]. Sestrin-induced activation of 
AMPK and inhibition of TORC1 can also reduce ROS 
production by increasing the efficiency of mitochondrial 
respiration [11,12]. Therefore, Sestrins have a key role 
in maintaining cellular integrity and homeostasis during 
oxidative insults. 
 
 
Hypoxia 
 
Hypoxia is another environmental stimulus that can 
induce Sestrin gene transcription [2]. Sestrins protect 
cells from apoptosis during hypoxic conditions [2], and 
Sestrin-induced shutdown of TORC1 signaling can 
reduce cellular energy consumption that is likely to 
improve adaptation to hypoxic conditions. Sestrin-
stimulated autophagy can provide an additional energy 
source and at the same time eliminate dysfunctional 
mitochondria generated by inefficient respiration under 
low oxygen tension.  Figure 1. Induction of dSesn after DNA damage.  First
instar fly larvae were challenged with 4000 rads (R) of gamma
radiation, and RNA was extracted after 4 hrs. Northern blot
analysis  revealed  that  dSesn  mRNA  is  highly  induced  upon
irradiation. rp49 mRNA was used as a loading control. 
 
Ischemic injury to heart muscles and neurons, which is 
caused by hypoxia, is one of the major causes of death 
in elderly individuals [18]. In an experimental model of 
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upon hypoxic injury [2], suggesting that Sesn2 may 
exert its neuroprotective role during stroke. In the heart, 
hypoxic injury and re-oxygenation cause bursts of ROS 
production, which can cause irreversible damage to the 
heart muscle, resulting in cardiac arrhythmia and heart 
failure [35,36]. In the Drosophila heart, both aging [37-
41] and hypoxia [39,42,43] cause cardiac dysfunction, 
and activation of TORC1 pathway aggravates or 
accelerates age-associated arrhythmicity and heart 
failure [44]. Loss of dSesn function results in a similar 
cardiac arrhythmicity [4], suggesting a cardio-protective 
function of Sestrin in restraining TORC1 activity. Thus 
Sestrin expression retards the appearance of age-
associated cardiac pathologies, as was previously 
observed in response to genetic reduction of TORC1 
function [10,44]. 
 
Hypoxic preconditioning can protect both heart and 
neuronal cells from severe ischemic injury-induced 
cellular damage [36,45], but the underlying mechanisms 
were not elucidated. Induction of autophagy upon 
preconditioning was suggested to be required for 
protection of heart and neuronal cells from hypoxic 
insults [36,46]. An intriguing possibility to investigate 
therefore  is  whether  hypoxic  preconditioning  induces  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sestrin to increase the level of autophagy that is 
required for the prevention of serious heart attacks and 
neurological strokes. 
 
An evolvable link to the environment 
 
In addition to the important role that Sestrins play in 
mediating essential environmental inputs into metabolic 
regulation, these molecules may also play central roles 
in responding to other environmental cues such as 
nutrient supply, hydration status, temperature, chemical 
damage, and reproductive signals. One might speculate 
that because these various cues would have different 
impacts on different organisms, Sestrin genes should 
have evolved complex cis-regulatory regions to place 
them under distinct regulatory controls that vary from 
one organism to another. Indeed, our analysis of Sestrin 
genomic loci revealed that these sequences are rapidly 
evolving among the various Drosophila species. For 
example, the disposition and number of FoxO binding 
sites in the Sestrin locus vary significantly among species 
(Figure 2). Comparative studies of cis-regulatory 
sequences between Drosophila species by swapping these 
sequences using recombineering techniques may shed 
light on mechanisms by which selective pressures sculpt 
the stress response during evolution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.  FoxO  binding  sites  in  the  Sestrin locus  vary  among  the  species.  Genomic
organization and location of FoxO response elements (FRE, GTAAACAA [57]) in the Sesn1 locus of
human and mouse [58] and the dSesn locus of various Drosophila species [59,60] with indicated
genomic span. Gray boxes indicate untranslated exons (UTR), and black boxes indicate coding exons
(CDS). For Drosophila species other than D. melanogaster, untranslated regions of dSesn mRNAs are
currently unknown. Forward FREs are indicated by red arrows and reverse FREs by blue arrows. 
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Concluding remarks 
 
In this research perspective, we briefly reviewed how 
Sestrins may act as suppressors of aging that are 
responsive to stressful stimuli and insults that can 
accelerate the aging process. By activating AMPK and 
inhibiting TORC1, Sestrins can reprogram cells to adapt 
to stressful conditions by attenuating anabolism and 
enhancing autophagic catabolism. Sestrins can suppress 
oxidative damage by acting as either antioxidants, 
inducers of autophagy that eliminate ROS-producing 
dysfunctioning mitochondria, or suppressors of ROS-
producing mitochondrial metabolism. Therefore, we can 
view Sestrins as physiological brakes that can attenuate 
stress-dependent acceleration of aging (Figure 3). 
 
In addition, it is worth noting that Sestrins are also 
expressed under normal unstressed conditions [1,2,4], 
and that dSesn knockout mutants show accelerated 
aging phenotypes even in the absence of any 
environmental stress [4]. Therefore, it is possible that 
Sestrins provide a baseline protective function that 
reduces the damage from physiological insults that are 
unavoidable consequences of basic life processes such 
as oxidative respiration and DNA replication. 
 
Over-nutrition and obesity can elevate the incidence and 
frequency of physiological insults by stimulating 
TORC1 activity [47], which in turn accelerates anabolic 
metabolism [16,17]. Hyperactive TORC1 can enhance 
the accumulation of unfolded and aggregated proteins 
[48] and ROS [4,12,49], leading to stress responses that 
increase Sestrin  expression,  thereby activating negative  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic diagram hypothesizing the role of Sestrin as a brake of
stress‐accelerated  aging  processes.  Various  environmental  insults  increase
expression of Sestrins to affect Sestrin‐mediated regulation of AMPK‐TORC1 signaling. 
 
 
 
 
feedback loops that readjust AMPK and TORC1 
activity [4]. Therefore, Sestrins may also function as 
metabolic brakes that attenuate the pathological 
consequences of over-nutrition and its associated 
TORC1 hyperactivity [50]. An interesting human 
evolutionary question in this regard is whether 
regulation of Sestrin induction has been weakened in 
populations subject to frequent starvation conditions 
since such populations have been shown to be 
particularly at risk for obesity, presumably as a result of 
their altered response to nutrient cues [51,52]. 
 
Although environmental stress generally accelerates 
aging, it should be considered that exposure to a low 
level of stress or stress adaptation can actually be 
beneficial for the organism, increasing life span and 
preventing age-associated degenerative diseases [53-
56]. The beneficial effect of low-level stress exposure, 
referred to as hormesis, was observed in both 
experimental animal models and human subjects [53-
56], but no decisive molecular explanation has been 
provided to explain this paradoxical phenomenon. 
Given that Sestrins are upregulated in response to a 
variety of stresses [1,2], it will be interesting to 
investigate whether stress-induced Sestrins are also 
mediators of the hormetic effect. 
 
In summary, we suggest that Sestrins are uniquely 
poised at the crossroads between stress and aging to 
adjust the metabolic timbre of an organism to meet its 
needs under normal conditions and to respond to 
predictable forms of environmental stress.  Future 
experiments should shed light on the specific 
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the Sestrins are achieved. 
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